Rep. Richard Dean Dr McCormick files a Periodic Transaction Report

A single congressional trade disclosure has no mechanism to resolve any underlying market condition or policy question; this branch would require the filing itself to trigger legislative action on financial regulation or transparency, which is not suggested by a routine Berkshire Hathaway purchase.

Individual congressional stock purchases are typically absorbed into normal market flow without measurable price impact, and a $1–15k position in Berkshire Hathaway by a single lawmaker would plausibly remain a minor data point among millions of daily trades.

If this trade were to become part of a broader pattern—such as multiple lawmakers buying or selling the same security ahead of sector-specific legislation—it could fuel scrutiny of congressional trading practices and potentially trigger calls for stricter STOCK Act enforcement or insider-trading investigations, which would create reputational and regulatory risk for affected members.